Serum BAFF Levels and B Cell Subsets in Secondary Lymphoid Organs after Rituximab Administration: Its Association with Clinical Outcomes
| Project/Area Number |
25861408
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Urology
|
|---|
| Research Institution | Akita University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2013-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2014: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | 腎移植 / 免疫学的ハイリスク / Rituximab / 二次リンパ組織 / 抗体関連型拒絶反応 / ＢＡＦＦ / Ｂ細胞レパートリー / Bリンパ球 / 形質細胞 / BAFF / リツキシマブ / 2次リンパ節 / 抗CD20抗体 / 脱感作療法 / CD138 |
|---|
| Outline of Final Research Achievements |
<Introduction and Objective> Although CD20+ cells in peripheral blood and spleen are consistently depleted in patients receiving Rituximab (RIT), the clinical effects are heterogeneous, probably related to differences in the depleting effects of lymph node(LN)s. <Methods> 52 patients with immunological high risks received a single dose of RIT at 3 weeks before kidney transplant. Immunohistochemical intensity of B cell subsets (CD20, CD27, CD79a, and CD138) in LN was scored. Serum BAFF levels post-transplant were measured by ELISA. <Results> The intensity score of CD138 in LNs was significantly higher in ABMR patients (p<0.01) than those in non-ABMR. The intensity score of CD138 in LNs, and low serum BAFF level at 7 days before transplant were significantly associated with the occurrence of ABMR. <Conclusion> In immunological high risk kidney transplant recipients receiving RIT before transplant, the plasma cell intensity in LNs and low serum BAFF level were risk factors of ABMR.
|
Report
(3 results)
Research Products
(8 results)
